According to the alternative genetic DLBCL classifications, CD79B mutations are enriched in Cluster 5, MYD88, and MCD2-S genetic subtypes, which are all MCD cluster equivalents [54,55,58]. This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.